Non-IgE-Mediated Rhinitis

Papers of particular interest, published recently, have been highlighted as: • Of importance

1. 1.
   Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen). Allergy. 2008;63(Suppl 86):8–160.PubMedCrossRefGoogle Scholar
2. 2.
   Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;86(5):494–507; quiz-8.PubMedCrossRefGoogle Scholar
3. 3.
   Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378(9809):2112–22.PubMedCrossRefGoogle Scholar
4. 4.
   • Hellings PW, Scadding G, Alobid I, Bachert C, Fokkens WJ, Gerth van Wijk R, et al. Executive summary of European Task Force document on diagnostic tools in rhinology. Rhinology. 2012;50(4):339–52. This task force document written by the ENT section of the EAACI summarizes the most important diagnostic tools available for the rhinologist in 2012. Google Scholar
5. 5.
   Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy. 2008;63(7):842–53.PubMedCrossRefGoogle Scholar
6. 6.
   Gwaltney JM Jr., Jones JG, Kennedy DW. Medical management of sinusitis: educational goals and management guidelines. The International Conference on sinus Disease. Ann Otol Rhinol Laryngol Suppl. 1995;167:22–30.PubMedGoogle Scholar
7. 7.
   Ruiz JN, Belum VR, Boers-Doets CB, Kamboj M, Babady NE, Tang YW, et al. Nasal vestibulitis due to targeted therapies in cancer patients. Suppor Care Cancer. 2015;23(8):2391–8.CrossRefGoogle Scholar
8. 8.
   van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev. 2008;4:CD006216.PubMedGoogle Scholar
9. 9.
   Doshi J. Rhinitis medicamentosa: what an otolaryngologist needs to know. Eur Arch Otorhinolaryngol. 2009;266(5):623–5.PubMedCrossRefGoogle Scholar
10. 10.
    Varghese M, Glaum MC, Lockey RF. Drug-induced rhinitis. Clin Exp Allergy. 2010;40(3):381–4.PubMedCrossRefGoogle Scholar
11. 11.
    Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68(5):975–83.PubMedCrossRefGoogle Scholar
12. 12.
    Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98(1):76–85.PubMedCrossRefGoogle Scholar
13. 13.
    Olsen KD, Neel HB III, Deremee RA, Weiland LH. Nasal manifestations of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Otolaryngol Head Neck Surg. 1980;88(1):85–9.PubMedGoogle Scholar
14. 14.
    Del Martinez PM, Sivasothy P. Vasculitis of the upper and lower airway. Best Pract Res Clin Rheumatol. 2009;23(3):403–17.CrossRefGoogle Scholar
15. 15.
    Sproson EL, Jones NS, Al-Deiri M, Lanyon P. Lessons learnt in the management of Wegener’s Granulomatosis: long-term follow-up of 60 patients. Rhinology. 2007;45(1):63–7.PubMedGoogle Scholar
16. 16.
    Zeitlin JF, Tami TA, Baughman R, Winget D. Nasal and sinus manifestations of sarcoidosis. Am J Rhinol. 2000;14(3):157–61.PubMedCrossRefGoogle Scholar
17. 17.
    Ellegard E, Hellgren M, Toren K, Karlsson G. The incidence of pregnancy rhinitis. Gynecol Obstet Invest. 2000;49(2):98–101.PubMedCrossRefGoogle Scholar
18. 18.
    Ellegard EK, Karlsson NG, Ellegard LH. Rhinitis in the menstrual cycle, pregnancy, and some endocrine disorders. Clin Allergy Immunol. 2007;19:305–21.PubMedGoogle Scholar
19. 19.
    Navarrete-Palacios E, Hudson R, Reyes-Guerrero G, Guevara-Guzman R. Correlation between cytological characteristics of the nasal epithelium and the menstrual cycle. Arch Otolaryngol Head Neck Surg. 2003;129(4):460–3.PubMedCrossRefGoogle Scholar
20. 20.
    Hox V, Desai A, Bandara G, Gilfillan AM, Metcalfe DD, Olivera A. Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production. J Allergy Clin Immunol. 2015;135(3):729–36; e5.PubMedCrossRefGoogle Scholar
21. 21.
    Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–74.PubMedCrossRefGoogle Scholar
22. 22.
    Ellegard E, Ellegard L. Nasal airflow in growth hormone treatment. Rhinology. 1998;36(2):66–8.PubMedGoogle Scholar
23. 23.
    Rollin M, Seymour K, Hariri M, Harcourt J. Rhinosinusitis, symptomatology & absence of polyposis in children with primary ciliary dyskinesia. Rhinology. 2009;47(1):75–8.PubMedGoogle Scholar
24. 24.
    Kerrebijn JD, Poublon RM, Overbeek SE. Nasal and paranasal disease in adult cystic fibrosis patients. Eur Respir J. 1992;5(10):1239–42.PubMedGoogle Scholar
25. 25.
    Moscato G, Vandenplas O, Gerth Van Wijk R, Malo JL, Quirce S, Walusiak J, et al. Occupational rhinitis. Allergy. 2008;63(8):969–80.PubMedCrossRefGoogle Scholar
26. 26.
    • Hox V, Steelant B, Fokkens W, Nemery B, Hellings PW. Occupational upper airway disease: how work affects the nose. Allergy. 2014;69(3):282–91. This review summarizes the complex pathology of occupational rhinitis and rhinosinusitis and the most updated information on its’ epidemiology and pathophysiology. Google Scholar
27. 27.
    Meggs WJ. RADS and RUDS—the toxic induction of asthma and rhinitis. J Toxicol Clin Toxicol. 1994;32(5):487–501.PubMedCrossRefGoogle Scholar
28. 28.
    de Fatima ME, Algranti E. Medina Coeli ME, Antonio BM. Rhinitis and asthma symptoms in non-domestic cleaners from the Sao Paulo metropolitan area, Brazil. Occup Environ Med. 2007;64(7):446–53.CrossRefGoogle Scholar
29. 29.
    Jacobs JH, Spaan S, van Rooy GB, Meliefste C, Zaat VA, Rooyackers JM, et al. Exposure to trichloramine and respiratory symptoms in indoor swimming pool workers. Eur Respir J. 2007;29(4):690–8.PubMedCrossRefGoogle Scholar
30. 30.
    Bougault V, Turmel J, Boulet LP. Effect of intense swimming training on rhinitis in high-level competitive swimmers. Clin Exp Allergy. 2010;40(8):1238–46.PubMedCrossRefGoogle Scholar
31. 31.
    Meggs WJ, Elsheik T, Metzger WJ, Albernaz M, Bloch RM. Nasal pathology and ultrastructure in patients with chronic airway inflammation (RADS and RUDS) following an irritant exposure. J Toxicol Clin Toxicol. 1996;34(4):383–96.PubMedCrossRefGoogle Scholar
32. 32.
    Hox V, Vanoirbeek JA, Alpizar YA, Voedisch S, Callebaut I, Bobic S, et al. Crucial role of transient receptor potential ankyrin 1 and mast cells in induction of nonallergic airway hyperreactivity in mice. Am J Respir Crit Care Med. 2013;187(5):486–93.PubMedCrossRefGoogle Scholar
33. 33.
    Gerhold KA, Bautista DM. TRPA1: irritant detector of the airways. J Physiol. 2008;586(14):3303.PubMedCentralPubMedCrossRefGoogle Scholar
34. 34.
    • Eriksson J, Ekerljung L, Sundblad BM, Lotvall J, Toren K, Ronmark E, et al. Cigarette smoking is associated with high prevalence of chronic rhinitis and low prevalence of allergic rhinitis in men. Allergy. 2013;68(3):347–54. Properly conducted large-scale epidemiologic study on the effects of smoking on both allergic and non-allergic rhinitis. Google Scholar
35. 35.
    Benninger MS. The impact of cigarette smoking and environmental tobacco smoke on nasal and sinus disease: a review of the literature. Am J Rhinol. 1999;13(6):435–8.PubMedCrossRefGoogle Scholar
36. 36.
    Vachier I, Vignola AM, Chiappara G, Bruno A, Meziane H, Godard P, et al. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax. 2004;59(4):303–7.PubMedCentralPubMedCrossRefGoogle Scholar
37. 37.
    Bascom R, Kesavanathan J, Fitzgerald TK, Cheng KH, Swift DL. Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect. 1995;103(11):1026–30.PubMedCentralPubMedCrossRefGoogle Scholar
38. 38.
    Blank U, Ruckes C, Clauss W, Weber WM. Effects of nicotine on human nasal epithelium: evidence for nicotinic receptors in non-excitable cells. Pflugers Arch. 1997;434(5):581–6.PubMedCrossRefGoogle Scholar
39. 39.
    Morais-Almeida M, Pite H, Pereira AM, Todo-Bom A, Nunes C, Bousquet J, et al. Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy. 2013;68(9):1150–7.PubMedGoogle Scholar
40. 40.
    Settipane RA. Other causes of rhinitis: mixed rhinitis, rhinitis medicamentosa, hormonal rhinitis, rhinitis of the elderly, and gustatory rhinitis. Immunol Allergy Clin North Am. 2011;31(3):457–67.PubMedCrossRefGoogle Scholar
41. 41.
    Banner KH, Igney F, Poll C. TRP channels: emerging targets for respiratory disease. Pharmacol Ther. 2011;130(3):371–84.PubMedCrossRefGoogle Scholar
42. 42.
    van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongoing quest. Allergy. 2005;60(12):1471–81.PubMedCrossRefGoogle Scholar
43. 43.
    • Van Gerven L, Boeckxstaens G, Jorissen M, Fokkens W, Hellings PW. Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness. Laryngoscope. 2012;122(12):2615–20. This article describes an attractive and feasible scheme for the only method that is currently available to make a reliable diagnosis of NHR. Google Scholar
44. 44.
    Salib RJ, Harries PG, Nair SB, Howarth PH. Mechanisms and mediators of nasal symptoms in non-allergic rhinitis. Clin Exp Allergy. 2008;38(3):393–404.PubMedCrossRefGoogle Scholar
45. 45.
    • Van Gerven L, Boeckxstaens G, Hellings P. Up-date on neuro-immune mechanisms involved in allergic and non-allergic rhinitis. Rhinology. 2012;50(3):227–35. This review gives a nice overview of neurogenic pathways to which are often referred in this manuscript. Google Scholar
46. 46.
    van Rijswijk JB, Blom HM, KleinJan A, Mulder PG, Rijntjes E, Fokkens WJ. Inflammatory cells seem not to be involved in idiopathic rhinitis. Rhinology. 2003;41(1):25–30.PubMedGoogle Scholar
47. 47.
    Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31(6):864–72.PubMedCrossRefGoogle Scholar
48. 48.
    • Van Gerven L, Alpizar YA, Wouters MM, Hox V, Hauben E, Jorissen M, et al. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. J Allergy Clin Immunol. 2013;133(5):1332–9. This study describes results of Capsaicin treatment in IR patients along with the structural changes that are caused by the treatment and combines for the first time treatment results with an pathophysiological explanation of this promising therapy. Google Scholar
49. 49.
    • Rondon C, Campo P, Togias A, Fokkens WJ, Durham SR, Powe DG, et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129(6):1460–7. This review summarizes the extensive work that has been performed by the group of Rondon and colleagues to establish the highly debated concept of local allergic rhinitis. Google Scholar
50. 50.
    Rondon C, Dona I, Lopez S, Campo P, Romero JJ, Torres MJ, et al. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response. Allergy. 2008;63(10):1352–8.PubMedCrossRefGoogle Scholar
51. 51.
    Hox V, Bobic S, Callebaux I, Jorissen M, Hellings PW. Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters. Rhinology. 2010;48(4):426–32.PubMedGoogle Scholar
52. 52.
    Burgel PR, Cardell LO, Ueki IF, Nadel JA. Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps. Eur Respir J. 2004;24(4):594–600.PubMedCrossRefGoogle Scholar
53. 53.
    Blom HM, Godthelp T, Fokkens WJ, KleinJan A, Mulder PG, Rijntjes E. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol. 1997;100(6 Pt 1):739–47.PubMedCrossRefGoogle Scholar
54. 54.
    Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62(10):1111–8.PubMedCrossRefGoogle Scholar
55. 55.
    Braat JP, Mulder PG, Fokkens WJ, van Wijk RG, Rijntjes E. Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1748–55.PubMedCrossRefGoogle Scholar
56. 56.
    Gerth van Wijk R, Dieges PH. Nasal reactivity to histamine and methacholine: two different forms of upper airway responsiveness. Rhinology. 1994;32(3):119–22.PubMedGoogle Scholar
57. 57.
    American Thoracic S, European Respiratory S. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–30.CrossRefGoogle Scholar
58. 58.
    Bartley J, Fergusson W, Moody A, Wells AU, Kolbe J. Normal adult values, diurnal variation, and repeatability of nasal nitric oxide measurement. Am J Rhinol. 1999;13(5):401–5.PubMedCrossRefGoogle Scholar
59. 59.
    Lundberg JO, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrome. Eur Respir J. 1994;7(8):1501–4.PubMedCrossRefGoogle Scholar
60. 60.
    Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy. 2004;59(Suppl 76):16–22; discussion-3.PubMedCrossRefGoogle Scholar
61. 61.
    Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S103–15.PubMedCrossRefGoogle Scholar
62. 62.
    Lundblad L, Sipila P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2001;121(4):505–9.PubMedCrossRefGoogle Scholar
63. 63.
    Moscato G, Vandenplas O, van Wijk RG, Malo JL, Perfetti L, Quirce S, et al. EAACI position paper on occupational rhinitis. Respir Res. 2009;10:16.PubMedCentralPubMedCrossRefGoogle Scholar
64. 64.
    Dockhorn R, Aaronson D, Bronsky E, Chervinsky P, Cohen R, Ehtessabian R, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol. 1999;82(4):349–59.PubMedCrossRefGoogle Scholar
65. 65.
    Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol. 1993;11(1):1–7.PubMedCrossRefGoogle Scholar
66. 66.
    Graf K, Schaper C, Grafe M, Fleck E, Kunkel G. Glucocorticoids and protein kinase C regulate neutral endopeptidase 24.11 in human vascular smooth muscle cells. Basic Res Cardiol. 1998;93(1):11–7.PubMedCrossRefGoogle Scholar
67. 67.
    Bronsky EA, Druce H, Findlay SR, Hampel FC, Kaiser H, Ratner P, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol. 1995;95(5 Pt 2):1117–22.PubMedCrossRefGoogle Scholar
68. 68.
    Grossman J, Banov C, Boggs P, Bronsky EA, Dockhorn RJ, Druce H, et al. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. J Allergy Clin Immunol. 1995;95(5 Pt 2):1123–7.PubMedCrossRefGoogle Scholar
69. 69.
    Banov CH, Lieberman P, Vasomotor Rhinitis Study G. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001;86(1):28–35.PubMedCrossRefGoogle Scholar
70. 70.
    Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo. ORL J Otorhinolaryngol Relat Spec. 2001;63(2):76–81.PubMedCrossRefGoogle Scholar
71. 71.
    Gawlik R, Jawor B, Rogala B, Parzynski S, DuBuske L. Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients. Am J Rhinol Allergy. 2013;27(6):514–6.PubMedCrossRefGoogle Scholar
72. 72.
    Bernstein JA, Davis BP, Picard JK, Cooper JP, Zheng S, Levin LS. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol. 2011;107(2):171–8.PubMedCrossRefGoogle Scholar
73. 73.
    Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth van Wijk R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy. 1997;27(7):796–801.PubMedCrossRefGoogle Scholar
74. 74.
    Ciabatti PG, D’Ascanio L. Intranasal Capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial. Acta Otolaryngol. 2009;129(4):367–71.PubMedCrossRefGoogle Scholar
75. 75.
    Lacroix JS, Buvelot JM, Polla BS, Lundberg JM. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy. 1991;21(5):595–600.PubMedCrossRefGoogle Scholar
76. 76.
    Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PG, Blom HM, Fokkens WJ. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy. 2003;58(8):754–61.PubMedCrossRefGoogle Scholar
77. 77.
    Holland C, van Drunen C, Denyer J, Smart K, Segboer C, Terreehorst I, et al. Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist. Br J Clin Pharmacol. 2014;77(5):777–88.PubMedCentralPubMedCrossRefGoogle Scholar
78. 78.
    Mladina R, Risavi R, Subaric M. CO₂ laser anterior turbinectomy in the treatment of non-allergic vasomotor rhinopathia. A prospective study upon 78 patients. Rhinology. 1991;29(4):267–71.PubMedGoogle Scholar
79. 79.
    Sandhu AS, Temple RH, Timms MS. Partial laser turbinectomy: two year outcomes in patients with allergic and non-allergic rhinitis. Rhinology. 2004;42(2):81–4.PubMedGoogle Scholar
80. 80.
    Robinson SR, Wormald PJ. Endoscopic vidian neurectomy. Am J Rhinol. 2006;20(2):197–202.PubMedGoogle Scholar